Skip to main content

α-Galactosidase A Deficiency (Full Gene Sequencing)

CPT 81405
Synonyms
  • Anderson-Fabry Disease
  • Fabry Disease

Test Details

Methodology

DNA sequencing

Result Turnaround Time

18 - 21 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Use

Indications for testing: Patients with clinical features of Fabry disease, both male and female; carrier testing for females with affected male relatives; patients with left ventricular hypertrophy or cardiomyopathy who otherwise do not have a classic Fabry disease phenotype; parents, siblings, and possibly children of a patient known to carry a mutation in GLA gene; prenatal testing when a parent is diagnosed with Fabry disease and has an identified GLA mutation.

Limitations

This method does not detect large deletions, large duplications and genomic rearrangements, or deep intronic variants; it may be affected by allele-dropout.

Custom Additional Information

Fabry disease (Anderson-Fabry disease, α-galactosidase A deficiency) is a rare, panethnic, X-linked recessive lysosomal storage disorder (LSD) characterized by a deficiency in acid α-galactosidase A caused by mutations in the GLA gene. Deficiency of this enzyme leads to accumulation of glycogen within the lysosomes and cytoplasm resulting in tissue damage. Fabry disease is rare and occurs in an estimated 1 in 100,000 newborns. Since the disorder is an X-linked recessive disease, the mother has a 50% chance of passing the defective gene on to all offspring. Males who inherit the defective gene will have Fabry disease. Females who inherit the gene will be carriers. Because of X-chromosomal inactivation, some female carriers develop symptoms of mild, moderate, or classical Fabry disease. To date, more than 300 mutations and sequence variants have been identified, the majority being very rare.

Specimen Requirements

Specimen

Blood, amniotic fluid, or CVS

Volume

7 mL whole blood, 10 mL amniotic fluid, or 10 mg CVS

Container

Lavender-top (EDTA) tube or yellow-top (ACD) tube; sterile plastic conical tube; or two confluent T25 flasks for fetal testing

Storage Instructions

Maintain specimen at room temperature.

Causes for Rejection

Frozen specimen; hemolysis; quantity not sufficient for analysis; improper container

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
252225 GLA Sequencing 34515-7 252226 GLA Sequencing 34515-7
Order Code252225
Order Code NameGLA Sequencing
Order Loinc34515-7
Result Code252226
Result Code NameGLA Sequencing
UofM
Result LOINC34515-7